In response to emerging data on the increased risk of severe illness for pregnant individuals, Ontario’s Vaccine Clinical Advisory Group (VCAG) has recommended the inclusion of pregnant individuals in the Highest Risk category of health conditions. As part of this group, pregnant individuals and one primary caregiver are now eligible to receive their COVID-19 vaccines...
Tag: Pregnancy
Answering Patient Questions about COVID-19 Vaccines
Dear Patients, As you all know, the first vaccines are being given to higher-risk people and healthcare workers. But we look forward to when you all will have access to the vaccine. We do not yet know the place or the timing and we will communicate this when we do. Appropriate steps taken – The...
Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) beyond 20 weeks of pregnancy and risk of kidney damage in unborn babies, leading to low amniotic fluid
Health Canada is investigating the use of NSAIDs at 20 weeks or later in pregnancy and the rare, but serious, risk of kidney problems in an unborn baby that can lead to low levels of amniotic fluid and possible complications, in response to a Drug Safety Communication recently released by the U.S. FDA on this...
Whooping cough Vaccination in Pregnancy
NACI has just recently recommended Tdap ( Adacel or Boostrix) vaccine in every pregnancy between 27-32 weeks of gestation irrespective of previous immunization history due to rapid waning of pertussis maternal antibodies. It can be also administered as early as 13 weeks gestation up to time of delivery. It takes 4 weeks for the peak...
Important Safety Information on ALESSE 21 and ALESSE 28: Packages Containing Broken or Split Tablets
Health Canada and Pfizer Canada Inc. have received reports for packages of ALESSE 21 and ALESSE 28 where the blister packages contained a single active (pink) tablet that was broken. This could reduce the dose of hormones and potentially result in an unintended pregnancy due to insufficient action of the contraceptive hormones levonorgestrel and ethinyl...